Perceptions of medication safety among patients with inflammatory bowel disease

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 9, 2010, Pages 1076-1083

  Cullen, Garret ^a   Donnellan, Fergal ^a   Long, Syapiq ^a   Forry, Mary ^a   Murray, Frank E ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Inflammatory bowel disease; Medication; Patient perception; Safety

Indexed keywords

ADALIMUMAB; AMINOSALICYLIC ACID DERIVATIVE; AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE;

ADULT; ARTICLE; CROHN DISEASE; DRUG SAFETY; DRUG USE; FEMALE; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

ADULT; ANTI-INFLAMMATORY AGENTS; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PERCEPTION; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 77955535134     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2010.490595     Document Type: Article

References (15)

1. Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Diamond RH, Chen DM, et al. Serious infections and mortality in association with therapies for Crohns disease: TREAT registry. Clin Gastroenterol Hepatol 2006;4:621-630
2. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, et al. Maintenance infliximab for Crohns disease: the ACCENT I randomised trial. Lancet 2002;359:1541-1549
3. Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353:2462-2476 (Pubitemid 41770166)
4. DHaens G, Baert F, van Assche G, Caenepeel P, Vergauwe P, Tuynman H, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohns disease: an open randomised trial. Lancet 2008;371:660-667
5. Markowitz J, Grancher K, Kohn N, Lesser M, Daum F. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohns disease. Gastroenterology 2000;119:895-902.
6. Punati J, Markowitz J, Lerer T, Hyams J, Kugathasan S, Griffiths A, et al. Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Inflamm Bowel Dis 2008;14:949-954
7. Siegel CA, Levy LC, Mackenzie TA, Sands BE. Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease. Inflamm Bowel Dis 2008;14:1-6.
8. Baars JE, Siegel CA, Kuipers EJ, van der Woude CJ. Patients perspectives important for early anti-tumor necrosis factor treatment in inflammatory bowel disease. Digestion 2009;79: 30-35
9. Harvey RF, Bradshaw JM. A simple index of Crohns-disease activity. Lancet 1980;1:514.
10. Johnson FR, Ozdemir S, Mansfield C, Hass S, Miller DW, Siegel CA, et al. Crohns disease patients risk-benefit preferences: serious adverse event risks versus treatment efficacy. Gastroenterology 2007;133: 769-779
11. Cullen G, OToole A, Keegan D, Sheahan K, Hyland JM, ODonoghue DP. Long-term clinical results of ileocecal resection for Crohns disease. Inflamm Bowel Dis 2007; 13:1369-1373
12. Man-Son-Hing M, Laupacis A, OConnor AM, Biggs J, Drake E, Yetisir E, et al. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial. JAMA 1999;282: 737-743
13. Brundage MD, Feldman-Stewart D, Cosby R, Gregg R, Dixon P, Youssef Y, et al. Phase I study of a decision aid for patients with locally advanced non-small-cell lung cancer. J Clin Oncol 2001;19:1326-1335
14. Adam JA, Khaw FM, Thomson RG, Gregg PJ, Llewellyn-Thomas HA. Patient decision aids in joint replacement surgery: a literature review and an opinion survey of consultant orthopaedic surgeons. Ann R Coll Surg Engl 2008;90: 198-207.
15. Spiegel BM, Ho W, Esrailian E, Targan S, Higgins PD, Siegel CA, et al. Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists. Clin Gastroenterol Hepatol 2009;7: 168-74, 174.e1.